qPCR Amplification Of Human Gastrointestinal Samples

This content is brought to you by Integrated DNA Technologies, a Danaher Operating Company.

DNA extracted from gastrointestinal samples often carries residual inhibitors that compromise qPCR sensitivity, delay detection, and dampen fluorescence signals. Leveraging a one-step, broad-range master mix paired with a direct amplification enhancer offers a practical way to overcome these challenges. The approach improves tolerance to inhibitor carryover, delivers stronger fluorescence, and enables earlier detection of key microbial targets compared to a commonly used alternative mix. The result is more reliable amplification from complex matrices without additional cleanup steps—supporting faster, more confident insights from difficult samples. For teams working with GI-derived material, this strategy can streamline workflows while improving data quality.

Explore the data to see how enhanced chemistry translates into clearer signals and more consistent performance across inhibitor-rich samples.